In support of this, it has been demonstrated that angiotensin type 1 receptor (AT1R) blockers inhibit oxidative stress activity in the heart in the setting of hypertension (Bayorh et al., 2003; Dohi et al., 2003) independently of their effect on blood pressure. The gene discussed is AGTR1; the disease is hypertensive disorder.